exsilio therapeutics inc:Exsilio Therapeutics - Products
Exsilio Therapeutics - Products
ExsilioTherapeuticsfocusesonthedevelopmentofgenomicmedicineswithinthebiotechnologysector.Thecompanyspecializesininsertingtherapeuticgenes ...。其他文章還包含有:「ExsilioLaunchesWith$82MtoTackleGeneTherapy...」、「ExsilioSolutions」、「ExsilioTherapeutics」、「ExsilioTherapeutics」、「ExsilioTherapeuticsCompanyProfile2024」、「ExsilioTherapeuticsLauncheswith$82MillionSeriesA...」、「EXSILIOTHE...
查看更多 離開網站Exsilio Launches With $82M to Tackle Gene Therapy ...
https://www.biospace.com
Exsilio Therapeutics emerged from stealth on Tuesday with a platform that leverages mRNA technology to develop redosable genomic medicines ...
Exsilio Solutions
https://exsilio.com
Full spectrum solutions · Enterprise & Cloud Applications · Data Analytics, Insights & AI · UX, UI & Interaction Design · Quality Engineering · IT Consulting &
Exsilio Therapeutics
https://exsiliotx.com
Exsilio is developing genomic medicines that insert therapeutic genes into safe harbors within the DNA. Backed by leading investors, we're on a mission to ...
Exsilio Therapeutics
https://www.crunchbase.com
Exsilio develops genomic therapeutics that introduce therapeutic genes into safe shelters within the DNA. Boston, Massachusetts, United States ...
Exsilio Therapeutics Company Profile 2024
https://pitchbook.com
Manufacturer of genomic medicines intended to transform the treatment of a broad range of diseases. The company develops medicines that can be delivered in ...
Exsilio Therapeutics Launches with $82 Million Series A ...
https://www.prnewswire.com
Exsilio Therapeutics is developing genomic medicines that can be delivered in lipid nanoparticles to durably and safely treat a broad range of ...
EXSILIO THERAPEUTICS LTD
https://www.kycisrael.com
Israel business registry report on EXSILIO THERAPEUTICS LTD, including information on company directors and shareholders.
OrbiMed on LinkedIn
https://www.linkedin.com
Exsilio Therapeutics Launches with $82 Million Series A Financing to Develop Redosable Genomic Medicines for A Broad Range of Diseases.
Örn Almarsson on LinkedIn
https://www.linkedin.com
Exsilio Therapeutics Launches with $82 Million Series A ... Therapeutics BlossomHill Therapeutics, Inc. BJ Sullivan, PhD, BioAge ...